RBA vs TECH · P/E 53, rev $4.28B vs P/E 65, rev $1.22B
RB Global Inc. (RBA) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
RB Global Inc. (RBA) is a specialty business services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported RBA revenue for 2024-12-31 was $4.28B. Net income was $412.8M. Revenue was up 16.4% from 2023-12-31 to 2024-12-31. RBA currently screens at market cap $20.03B and trailing P/E 53.0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
RBA currently screens at market cap $20.03B and trailing P/E 53.0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the RBA and TECH stock pages for the full models.
Not investment advice.